Treatment of patients with schizophrenia and comorbid substance use disorders

被引：0

作者：

Dilbaz, Nesrin ^{[2
]}

Darcin, Asli Enez ^{[1
]}

机构：

[1] Hastanesi Psikiyatri Klin, Kayseri, Turkey

[2] Hastanesi 2 Psikiyatri Klin, Ankara, Turkey

来源：

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 21卷 / 01期

关键词：

Schizophrenia; alcohol; substance; comorbidity; treatment; INDUCED PSYCHOTIC DISORDER; PLACEBO-CONTROLLED TRIAL; CANNABIS USE; SMOKING-CESSATION; DRUG-ABUSE; ANTIPSYCHOTIC MEDICATIONS; ATYPICAL ANTIPSYCHOTICS; RESISTANT SCHIZOPHRENIA; OLANZAPINE TREATMENT; COCAINE DEPENDENCE;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Almost half of schizophrenic patients also present with a lifetime history of substance use disorders, a rate that is much higher than that seen in the general population. Although this comorbidity is associated with poorer clinical outcomes, treatments of these patients rarely target substance use. This paper provides a review of the literature on treatment of substance use disorders in schizophrenic patients.

引用

页码：80 / 90

页数：11

共 109 条

[1] Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia [J].